Quick10K

⚲

Mercer

Filings

10-Q	2021-03-31	Filed 2021-04-29
10-K	2020-12-31	Filed 2021-02-16
10-Q	2020-09-30	Filed 2020-10-29
10-Q	2020-06-30	Filed 2020-07-31
10-Q	2020-03-31	Filed 2020-04-30
10-K	2019-12-31	Filed 2020-02-13
10-Q	2019-09-30	Filed 2019-10-31
10-Q	2019-06-30	Filed 2019-08-01
10-Q	2019-03-31	Filed 2019-05-02
10-K	2018-12-31	Filed 2019-02-14
10-Q	2018-09-30	Filed 2018-10-25
10-Q	2018-06-30	Filed 2018-07-26
10-Q	2018-03-31	Filed 2018-05-03
10-K	2017-12-31	Filed 2018-02-16
10-Q	2017-09-30	Filed 2017-10-26
10-Q	2017-06-30	Filed 2017-07-27
10-Q	2017-03-31	Filed 2017-04-28
10-K	2016-12-31	Filed 2017-02-10
10-Q	2016-09-30	Filed 2016-10-27
10-Q	2016-06-30	Filed 2016-07-28
10-Q	2016-03-31	Filed 2016-04-28
10-K	2015-12-31	Filed 2016-02-12
10-Q	2015-09-30	Filed 2015-10-29
10-Q	2015-06-30	Filed 2015-07-30
10-Q	2015-03-31	Filed 2015-04-30
10-K	2014-12-31	Filed 2015-02-13
10-Q	2014-09-30	Filed 2014-10-31
10-Q	2014-06-30	Filed 2014-08-01
10-Q	2014-03-31	Filed 2014-05-02
10-K	2013-12-31	Filed 2014-02-21
10-Q	2013-09-30	Filed 2013-11-01
10-Q	2013-06-30	Filed 2013-08-02
10-Q	2013-03-31	Filed 2013-05-03
10-K	2012-12-31	Filed 2013-02-15
10-Q	2012-09-30	Filed 2012-11-02
10-Q	2012-06-30	Filed 2012-08-03
10-Q	2012-03-31	Filed 2012-05-07
10-K	2011-12-31	Filed 2012-02-21
10-Q	2011-09-30	Filed 2011-11-07
10-Q	2011-06-30	Filed 2011-08-04
10-Q	2011-03-31	Filed 2011-05-09
10-K	2010-12-31	Filed 2011-02-17
10-Q	2010-09-30	Filed 2010-11-04
10-Q	2010-06-30	Filed 2010-08-05
10-Q	2010-03-31	Filed 2010-05-04
10-K	2009-12-31	Filed 2010-02-26

Reports

8-K	2020-09-30
8-K	2020-06-30
8-K	2020-06-22
8-K	2020-05-29
8-K	2020-05-15
8-K	2020-03-31
8-K	2020-02-13
8-K	2019-10-31
8-K	2019-10-03
8-K	2019-09-19
8-K	2019-09-19
8-K	2019-08-01
8-K	2019-05-31
8-K	2019-05-02
8-K	2019-04-16
8-K	2019-02-14
8-K	2018-12-19
8-K	2018-12-10
8-K	2018-12-07
8-K	2018-11-29
8-K	2018-11-28
8-K	2018-10-25
8-K	2018-10-03
8-K	2018-07-26
8-K	2018-06-01
8-K	2018-05-25
8-K	2018-05-03
8-K	2018-02-15
8-K	2018-01-01

Mercer Financials

MERC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	152	128	105	124	131	126	104	111	134	134	148	172	241	240	53	100	91	137	100	130	113	141	137	184	143	159	461	214	269	242	240	233	257	265
Accounts Receivable	104	110	120	117	104	119	110	120	97	97	136	149	135	139	141	136	153	139	134	137	125	131	124	135	178	181	206	213	191	194	253	309	274	228
Inventory	104	128	121	108	118	113	118	113	108	123	171	150	165	154	147	136	141	140	141	134	135	144	133	125	145	164	177	185	189	230	304	282	287	269
PP&E	824	816	821	813	817	816	1,325	803	789	777	1,799	1,015	1,007	924	1,626	779	800	784	1,481	792	767	780	1,509	735	823	845	1,789	852	836	834	2,004	1,022	1,032	1,010
Assets	1,230	1,231	1,217	1,213	1,226	1,221	1,184	1,186	1,172	1,176	1,549	1,547	1,609	1,548	1,327	1,234	1,268	1,272	1,183	1,238	1,180	1,233	1,159	1,202	1,328	1,386	1,725	1,507	1,522	1,541	1,976	2,013	2,030	1,950
Accounts Payable							30				44				34			29	21	26	26	27	29	29	45	37	36	43	49	47	36	40	39	44
Long-Term Debt	753	733	734	724	730	712	711	713	724	720	979	949	945	847	688	684	683	670	650	627	627	635	627	650	679	680	975	696	711	707	1,059	1,025	1,000	1,000
Liabilities	956	944	934	925	936	932	905	910	913	914	1,200	1,185	1,183	1,073	888	892	878	879	800	801	780	814	780	807	883	888	1,174	923	984	971	1,394	1,393	1,383	1,358
Stockholders' Equity	290	304	302	307	343	341	335	330	312	300	412	414	465	475	439	342	390	393	383	438	400	419	379	395	445	498	551	584	539	570	581	621	647	591


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	231	205	229	216	218	223	188	198	210	203	477	306	388	302	283	258	267	271	238	254	218	238	222	243	283	305	338	368	347	331		484	426	384
Cost of Revenue	186	161	215	189	191	206	172	180	200	181	437	256	326	242
Gross Profit	45	44	14	26	27	17	17	18	10	22	40	50	62	59
R&D
SG&A	9	9	11	10	10	10	10	9	9	9	23	10	14	11	13	11	12	12	11	12	10	10	12	10	13	12	14	14	15	15		17	19	18
Tax	0	1	1	3	2	2	1	1	1	2	4	2	5	1	1	0	0	0	8	5	8	5	5	7	8	7	3	10	8	10		24	15	3
Net Income	16	8	-2	2	6	1	-5	2	2	1	-14	23	24	92	3	14	16	24	22	9	-4	12	18	10	-2	21	42	26	17	41		52	10	1


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	32	1	3	36	53	9	-17	22	31	6	-9	60	76	37	27	60	10	72	17	63	11	36	30	53	16	34	39	76	86	11		42	89	57
Cash Investing	-7	-11	-21	-8	-1	4	-9	-3	-3	10	-16	-4	-1	19	-23	-8	-13	-10	-19	-8	-11	-9	-16	-8	-81	-15	-17	-16	-29	-27		-20	-25	-37
Cash Financing	4	-16	-7	-8	4	-1	4	5	28	25	-0	1	54	-0	-189	1	-10	-13	-34	-31	-14	1	-18	2	16	-8	279	-308	9	-13		-29	-40	-11